| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $19.5B | $21.9B | $14.5B | $5.7B | $16.2B | $4.2B | $1.1B | $-0.2B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $2.4B | $3.1B | $3.7B | $-0.8B | $4.7B | $2.0B | $0.5B | $-0.4B |
| EPS (Basic) | — | — | — | — | — | — | — | — |
| EPS (Diluted) | — | — | — | — | — | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $410.1B | $360.1B | $317.3B | — | — | $79.8B | $60.9B | $50.7B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | — | $5.4B | $2.3B | $1.8B |
| Total Liabilities | $328.5B | $298.1B | $258.9B | — | — | $39.0B | $30.4B | $25.4B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $30.9B | $23.7B | $22.9B | — | $17.6B | $13.7B | $10.8B | $8.6B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.5B | $6.6B | $-1.5B | $-5.3B | $-7.2B | $-6.0B | $-5.7B | $-7.6B |
| Investing Cash Flow | $-16.3B | $-19.0B | $-3.9B | $-13.6B | $-9.6B | $-0.2B | $-0.2B | $-0.1B |
| Capital Expenditures | — | — | — | — | — | — | $0.2B | $0.1B |
| Financing Cash Flow | $17.4B | $7.1B | $12.8B | $22.1B | $20.4B | $9.8B | $6.5B | $6.6B |